TRILOGY at ESC: No Advantage for Prasugrel Over Clopidogrel in Medical ACS Patients

The newer antiplatelet agent prasugrel was no better than the old standby clopidogrel for treating patients with acute coronary syndrome (ACS) who are...

To continue reading, please log in to the right or request an invitation.